Dinucleotide repeat polymorphism within the tumor suppressor gene PTCH at 9q22

Clinical Genetics

Volumn 54, Issue 3, 1998, Pages 239-241

  Louhelainen, Jari ^a   Lindström, Erica ^a   Hemminki, Kari ^a   Toftgård, Rune ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chromosome 9q; Dinucleotide repeat polymorphism; PTCH gene

Indexed keywords

ARTICLE; CHROMOSOME 9Q; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; GENE LOCATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031717394     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb04292.x     Document Type: Article

References (12)

1. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996: 85: 841-851.
2. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn EH, Myers RM, Cox DR, Epstein Jr. EH, Scott MP. Human homolog of patched, a candidate gene for the basal cell nervous syndrome. Science 1996: 272: 1668-1671.
3. Sidransky D. Is human patched the gatekeeper of common skin cancers? Nat Genet 1996: 14: 7-8.
4. Unden AB, Zaphiropoulos PG, Bruce K, Toftgård R, Ståhle-Bäckdahl M. Human patched (PTCH) mRNA is over-expressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res 1997: 57: 2336-2340.
5. Vorechovsky I, Unden AB, Sandstedt B, Toftgård R, Ståhle-Bäckdahl M. Trichoepitheliomas contain somatic mutations in the over-expressed PTCH gene. Support for a gatekeeper mechanism in skin tumorigenesis. Cancer Res 1997: 57: 4677-4681.
6. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J, Sorensen N, Berthold F, Henk B, Schmandt N, Wolf HK, von Deimling A, Wainwright B, Chenevix-Trench G, Wiestler OD, Wiking C. Medulloblastomas of the demoplastic variant carry mutations of the human homolog of Drosophila patched. Cancer Res 1997: 57: 2085-2088.
7. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, James CD. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997: 57: 842-845.
8. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. Mutations in the human homolog of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumours of the central nervous system. Cancer Res 1997: 57: 2581-2585.
9. Vorechovsky I, Tingby O, Hartman M, Strömberg B, Nister M, Collins VP, Toftgård R. Somatic mutations in the human homolog of Drosophila patched in primitive neuroectodermal tumours. Oncogene 1997: 15: 361-366.
10. Gailani MR, Ståhle-Bäckdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE, Toftgård R. The role of the human homolog of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996: 14: 78-81.
11. Wicking C, Gillies S, Smyth I, Shanley S, Fowles L, Ratcliffe J, Wainwright B, Chenevix-Trench G. De novo mutations of the patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype. Am J Med Genet 1997: 73: 304-307.
12. Richards FM, Goudie DR, Cooper WN, Jene Q, Barroso I, Wicking C, Wainwright BJ, Ferguson-Smith MA. Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes. Hum Genet 1997: 101: 317-322.